Pillstats
Rx only · Powder, For Suspension · Oral

Cholestyramine Powder For Suspension

Cholestyramine

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC10AC01
RxCUI (US)2447
US makers2 labelers
Packages5
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.138$0.275$0.413$0.550Dec 2025Feb 2026Jul 2026
$0.381
Latest avg · Jul 22, 2026
-20%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.6K3.1K4.7K6.2K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.1K
Rx · 2026 Q1
1.1M
Units dispensed
+15%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager3SUPPLYING
Ascend Laboratories, LLCunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.